
Starpharma’s COVID-19 nasal spray to be ready for market next quarter
The company is developing VIRALEZE™, an antiviral nasal spray for COVID-19 which is complementary to vaccines and other preventative measures such as distancing and PPE. Starpharma Holdings Limited (ASX:SPL) (OTCMKTS:SPHRF) has made strong commercial and …